Robert Klickovich, MD
Interventional Pain Medicine · Florence, KYNPI 1649204306
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Nevro Corp. at 54.8% of the total. Reporting peaked in 2019 at $33,379 and has fallen 93.2% since, to $2,268 in 2025. Among interventional pain medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 936 payments — averaging $60.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$31K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$6K
- Boston Scientific$3K
- Biodelivery Sciences International, Inc.$3K
- MML US, Inc.$2K
- Collegium Pharmaceutical, Inc.$1K
- plus $11K from 54 others
What the payments were for
- Consulting fees$9002%
- Speaking & faculty fees$31,80056%
- Travel & lodging$4,2578%
- Food & beverage$19,76835%
- Education$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Senza Spinal Cord Stimulation System$28,059
- LUCEMYRA$5,043
- BELBUCA$2,750
- ReActiv8$1,632
- Omnia$691
- Senza$494
- GENERAL PAIN MANAGEMENT$350
- INTELLIS ADAPTIVESTIM$302
- GENERATOR$146
- Prospera$139
- mild Device Kit$137
- Evoke$136
- SPINEJACK$124
- PROCLAIM$107
- WaveWriter Alpha Prime 16$107
- Lucemyra/Lofexidine$107
- Proclaim IPG$106
How this compares
$56,733 in reported general payments places this provider in the 95th percentile of 55 interventional pain medicine providers in Kentucky.
See all interventional pain medicine providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 157 | $87,173 |
| Fentanyl | 147 | $32,313 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,434 | $31,719 |
| OxycontinOxycodone Hcl | 25 | $24,035 |
| BelbucaBuprenorphine Hcl | 70 | $23,793 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,509 | $23,498 |
| Buprenorphine | 90 | $22,194 |
| Oxycodone Hcl | 643 | $15,164 |
| Gabapentin | 1,316 | $12,683 |
| GraliseGabapentin | 11 | $10,059 |
| LinzessLinaclotide | 11 | $9,719 |
| Aimovig AutoinjectorErenumab-Aooe | 12 | $8,886 |
| Morphine Sulfate ErMorphine Sulfate | 336 | $8,665 |
| Pregabalin | 397 | $7,335 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $7,137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $1,314 | $110,967227 claims |
| Almatica Pharma LLCGralise | $307 | $10,05911 claims |
| AbbVieLinzess | $968 | $9,71911 claims |
| Upsher-smith Laboratories LLCTopiramate | $70 | $97760 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 55 interventional pain medicine providers in Kentucky.
Other interventional pain medicine in Florence
- Michael FletcherFlorence$18K
- Bradley MullenFlorence$364
- Hammad MalikRichmond$35K
- Vishal BansalMadisonville$13K
- Anand ModaduguLexington$12K
- Zachary KlingerCorbin$10K
- Nathan LambornLouisville$10K
- Brock MarrsLexington$9K
- Brandon SuttonLouisville$9K
- Gary ReasorLouisville$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.